The Xeloda market, centered on the oral chemotherapy drug capecitabine, continues to play a pivotal role in the global oncology therapeutics landscape. Capecitabine is widely prescribed for treating colorectal, breast, and gastric cancers, offering patients a convenient oral alternative to traditional intravenous chemotherapy. Rising cancer prevalence, increased focus on patient-centric...